Golden Cross Gives Bulls Green Light?
One of the more unexpected tailwinds for healthcare stocks in recent years has been the weight-loss frenzy brought about most notably by Ozempic.
Novo Nordisk’s drug was such a hit that the share price soared by 62% over the past year alone. Yet it’s not the only game in town. Eli Lilly’s weight-loss drug,